Modulating smooth muscle cell response by the release of TGFβ2 from tubular scaffolds for vascular tissue engineering

Benjamin, 2018, Heart disease and stroke statistics—2018 update: a report from the American Heart Association, 137, e67 Nieponice, 2010, In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model, 16, 1215 Fukunishi, 2017, Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model, 153, 924 Ong, 2017, Tissue engineered vascular grafts: current state of the field, Exp. Rev. Med. Devices, 14, 383, 10.1080/17434440.2017.1324293 Wang, 2015, Origin and differentiation of vascular smooth muscle cells, J. Physiol., 593, 3013, 10.1113/JP270033 Rychter, 2017, Progress and perspectives in bioactive agent delivery via electrospun vascular grafts, RSC Adv., 7, 32164, 10.1039/C7RA04735E Han, 2014, 405 Boileau, 2012, TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome, Nat. Genet., 44, 916, 10.1038/ng.2348 Ramnath, 2015, Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels, Sci. Rep., 5, 10.1038/srep16872 Ardila, 2015, TGFβ2 differentially modulates smooth muscle cell proliferation and migration in electrospun gelatin-fibrinogen constructs, Biomaterials, 37, 164, 10.1016/j.biomaterials.2014.10.021 Artman, 2008 Azhar, 2011, Transforming growth factor Beta2 is required for valve remodeling during heart development, Dev. Dyn., 240, 2127, 10.1002/dvdy.22702 Doetschman, 2012, Transforming growth factor beta signaling in adult cardiovascular diseases and repair, Cell Tissue Res., 347, 203, 10.1007/s00441-011-1241-3 Braverman, 2015, J. Am. Coll. Cardiol., 66, 2398, 10.1016/j.jacc.2015.09.039 Molin, 2008, TGFb2 does not affect neural crest cell migration but is a key player in vascular remodeling during embryogenesis, Cardiovasc. Dev. Congenit. Malformations, 148 Agarwal, 2009, Progress in the field of electrospinning for tissue engineering applications, Adv. Mater., 21, 3343, 10.1002/adma.200803092 Hasan, 2014, Electrospun scaffolds for tissue engineering of vascular grafts, Acta Biomater., 10, 11, 10.1016/j.actbio.2013.08.022 Weng, 2015, Smart electrospun nanofibers for controlled drug release: recent advances and new perspectives, Curr. Pharm. Des., 21, 1944, 10.2174/1381612821666150302151959 Ji, 2011, Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications, Pharm. Res., 28, 1259, 10.1007/s11095-010-0320-6 Davidenko, 2016, Evaluation of cell binding to collagen and gelatin: a study of the effect of 2D and 3D architecture and surface chemistry, J. Mater. Sci. Mater. Med., 27, 148, 10.1007/s10856-016-5763-9 Guo, 2018, Fabrication of gelatin-micropatterned surface and its effect on osteogenic differentiation of hMSCs, J. Mater. Chem. B, 6, 1018, 10.1039/C7TB03165C Zhan, 2016, In vitro evaluation of electrospun gelatin–glutaraldehyde nanofibers, Front. Mater. Sci., 10, 90, 10.1007/s11706-016-0329-9 Zhang, 2016, Preparation, characterization, and evaluation of genipin crosslinked chitosan/gelatin three-dimensional scaffolds for liver tissue engineering applications, J. Biomed. Mater. Res. A, 104, 1863, 10.1002/jbm.a.35717 Wen, 2014, Mechanically Robust Gelatin–a lginate IPN hydrogels by a combination of enzymatic and ionic crosslinking approaches, Macromol. Mater. Eng., 299, 504, 10.1002/mame.201300274 Tamimi, 2016, Biomechanical comparison of glutaraldehyde-crosslinked gelatin fibrinogen electrospun scaffolds to porcine coronary arteries, J. Biomech. Eng., 138, 011001, 10.1115/1.4031847 Panzavolta, 2011, Electrospun gelatin nanofibers: optimization of genipin cross-linking to preserve fiber morphology after exposure to water, Acta Biomater., 7, 1702, 10.1016/j.actbio.2010.11.021 Wang, 2017, Biocompatibility and anti-calcification of a biological artery immobilized with naturally-occurring phytic acid as the crosslinking agent, J. Mater. Chem. B, 5, 8115, 10.1039/C7TB02090B Tsai, 2000, In vitro evaluation of the genotoxicity of a naturally occurring crosslinking agent (genipin) for biologic tissue fixation, J. Biomed. Mater. Res., 52, 58, 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0 Wang, 2016, Genipin crosslinking reduced the immunogenicity of xenogeneic decellularized porcine whole-liver matrices through regulation of immune cell proliferation and polarization, Sci. Rep., 6, 24779, 10.1038/srep24779 Zhang, 2005, Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds, J. Biomed. Mater. Res. Part B: Appl. Biomater., 72, 156, 10.1002/jbm.b.30128 Rajzer, 2014, Electrospun gelatin/poly (ε-caprolactone) fibrous scaffold modified with calcium phosphate for bone tissue engineering, Mater. Sci. Eng. C, 44, 183, 10.1016/j.msec.2014.08.017 Goyal, 2017, Development of hybrid scaffolds with natural extracellular matrix deposited within synthetic polymeric fibers, J. Biomed. Mater. Res. A, 105, 2162, 10.1002/jbm.a.36078 Norouzi, 2015, PLGA/gelatin hybrid nanofibrous scaffolds encapsulating EGF for skin regeneration, J. Biomed. Mater. Res. A, 103, 2225, 10.1002/jbm.a.35355 Fukunishi, 2016, Tissue-engineered small diameter arterial vascular grafts from cell-free nanofiber PCL/chitosan scaffolds in a sheep model, PLoS One, 11, 10.1371/journal.pone.0158555 Rnjak-Kovacina, 2011, Tailoring the porosity and pore size of electrospun synthetic human elastin scaffolds for dermal tissue engineering, Biomaterials, 32, 6729, 10.1016/j.biomaterials.2011.05.065 Heydarkhan-Hagvall, 2008, Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering, Biomaterials, 29, 2907, 10.1016/j.biomaterials.2008.03.034 Fu, 2014, Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering, Int. J. Nanomedicine, 9, 2335, 10.2147/IJN.S61375 Gautam, 2013, Fabrication and characterization of PCL/gelatin composite nanofibrous scaffold for tissue engineering applications by electrospinning method, Mater. Sci. Eng. C, 33, 1228, 10.1016/j.msec.2012.12.015 Munj, 2017, Understanding drug release from PCL/gelatin electrospun blends, J. Biomater. Appl., 31, 933, 10.1177/0885328216673555 Nada, 2016, Eco-friendly gelatin-based electrospun fibers to control the release of chloramphenicol, Fibers Polymers, 17, 1985, 10.1007/s12221-016-6596-3 Sohier, 2007, Tailored release of TGF-β1 from porous scaffolds for cartilage tissue engineering, Int. J. Pharm., 332, 80, 10.1016/j.ijpharm.2006.09.037 Wang, 2016, Evaluation of emulsion electrospun polycaprolactone/hyaluronan/epidermal growth factor nanofibrous scaffolds for wound healing, J. Biomater. Appl., 30, 686, 10.1177/0885328215586907 Wang, 2015, Enhanced vascularization in hybrid PCL/gelatin fibrous scaffolds with sustained release of VEGF, Biomed. Res. Int., 2015 Rose, 2014, Gelatin-based materials in ocular tissue engineering, Materials, 7, 3106, 10.3390/ma7043106 Butler, 2003, Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin, J. Polym. Sci. A Polym. Chem., 41, 3941, 10.1002/pola.10960 Lin, 1995, The soluble EXOPLASMIC domain of the type II transforming growth factor (TGF)-β receptor a HETEROGENEOUSLY GLYCOSYLATED PROTEIN WITH HIGH AFFINITY AND SELECTIVITY FOR TGF-β LIGANDS, J. Biol. Chem., 270, 2747, 10.1074/jbc.270.6.2747 Harrison, 2016, Computationally optimizing the compliance of a biopolymer based tissue engineered vascular graft, J. Biomech. Eng., 138, 014505, 10.1115/1.4032060